Subject Numbers Regarding Health Provider Authorizations
Authorization No. 290960-4B
June 3, 2024
Pursuant to Workers' Compensation Law (WCL) Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised her authority to temporarily suspend the authorization of Dr. Thomas Albus (hereinafter, "the provider") to treat injured workers and to perform independent medical examinations within the New York State workers' compensation system effective May 28, 2024. The provider 's last known business address is:
Patel Kao Pain and Rehab Associates LLC
601 Franklin Avenue
Suite 215
Garden City, New York 11530
The Chair's designee's investigation has revealed that on or about October 12, 2023, the Workers' Compensation Board's Medical Director's Office (MDO) served a letter upon the provider requesting a response within 20 days related to an independent medical examination complaint. To date, the MDO has not received a response.
Further, on or about May 16, 2024, the Chair's designee served a letter upon the provider requesting a response within 10 days to the October 12, 2023, letter from the MDO. To date, the Chair's designee has not received a response.
As a result of the foregoing, the Chair believes that the provider may be guilty of misconduct under WCL §13-d(2)(f) for the refusal to produce "any relevant book or paper concerning his or her conduct under any authorization granted to him or her under this chapter."
The provider is prohibited from rendering treatment and care to injured workers, and from conducting reviews of records regarding variance requests pursuant to 12 New York Codes, Rules and Regulations § 324.3(b)(2)(ii)(a), while her authorization is temporarily suspended. Reports submitted by the provider for services rendered prior to May 28, 2024, are valid but are invalid for any services rendered on or after that date. Requests to cross-examine the provider for services rendered prior to May 28, 2024, should not be denied due to the suspension of her authorization.
This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director's Office at 1 (800) 781-2362.
Clarissa M. Rodriguez
Chair